Syneos Health Appoints Two New Independent Directors
January 18, 2022 06:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022 09:06 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health to Present at Upcoming Investor Conferences
November 11, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...
Syneos Health Reports Third Quarter 2021 Results
November 03, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Schedules Third Quarter 2021 Earnings Call for Wednesday, November 3rd, 2021
October 19, 2021 09:32 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2021 financial...
Syneos Health Acquires RxDataScience
October 06, 2021 08:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of...
Syneos Health Acquires StudyKIK
September 14, 2021 17:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...
Syneos Health and Ride Health Partner to Improve Clinical Trial Recruitment and Retention
September 09, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic...
Novan Engages Syneos Health as Commercial Solutions Provider for SB206
September 08, 2021 09:00 ET
|
Novan, Inc.
– Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in...
Syneos Health Reports Second Quarter 2021 Results
August 09, 2021 06:12 ET
|
Syneos Health, Inc.
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year.Clinical Solutions net new business awards of $1,436.2 million for the second quarter,...